Kwang Nho is a prominent inventor based in Orinda, California. He has made significant contributions to the field of polyethylene glycol (PEG) derivatives, holding a total of seven patents. His work focuses on developing novel compounds that enhance the therapeutic efficacy of proteins.

Latest Patents

Among his latest patents is the invention of a novel monofunctional polyethylene glycol and its derivatives, which are modified with a tertiary alkoxy group. This innovation aims to improve the properties of PEG for various applications. Additionally, he has developed bifunctional polyethylene glycol derivatives that provide novel heterobifunctional and monobifunctional PEGs for the pegylation of therapeutically active proteins. These derivatives are designed for cross-linking purposes, which can occur either intramolecularly or intermolecularly. The pegylated protein conjugates produced from these innovations retain a substantial portion of their therapeutic activity while being less immunogenic than their unmodified counterparts.

Career Highlights

Kwang Nho is currently associated with Sun Bio, Inc., where he continues to advance his research in the field of biochemistry and drug development. His innovative approaches have positioned him as a key figure in the development of PEG-based therapeutics.

Collaborations

He collaborates with notable colleagues, including Perry Rosen and Changmin Hyun, who contribute to his research endeavors and help drive forward the innovations in PEG technology.

Conclusion

Kwang Nho's work in polyethylene glycol derivatives represents a significant advancement in therapeutic applications. His patents and ongoing research continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com